SCHEMBL21158164

SCHEMBL21158164

OCc1ccc(Oc2cccc(C(F)(F)F)c2)c(C2C=N2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 1/20 0.44
TTR P02766 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
AR P10275 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TEAD1 P28347 4/20 0.38
ICAM1 P05362 1/20 0.38
SELE P16581 1/20 0.38
PRKCA P17252 1/20 0.37
PRKCD Q05655 1/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.36
EGFR P00533 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL875489 0.80 AR (0.53) EPAS1TTRSMN1; SMN2ARL3MBTL1
SCHEMBL875278 0.80 EPAS1 (0.55) EPAS1TTRSMN1; SMN2ARL3MBTL1
SCHEMBL875557 0.80 EPAS1 (0.52) EPAS1TTRSMN1; SMN2ARL3MBTL1
SCHEMBL883499 0.80 EPAS1 (0.49) EPAS1TTRSMN1; SMN2ARL3MBTL1
SCHEMBL875580 0.79 FFAR1 (0.51) EPAS1TTREGFRERBB2ERBB3
SCHEMBL876331 0.79 EPAS1 (0.48) EPAS1TTRSMN1; SMN2ARL3MBTL1
SCHEMBL15278007 0.78 EPAS1 (0.47) EPAS1TTRSMN1; SMN2ARL3MBTL1
SCHEMBL11195440 0.76 PRKCA (0.50) EPAS1SMN1; SMN2L3MBTL1ALDH1A1POLB
SCHEMBL21731439 0.76 EPAS1 (0.48) EPAS1TTRSMN1; SMN2ARL3MBTL1
SCHEMBL875627 0.76 AR (0.57) EPAS1SMN1; SMN2ARPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3172211-B1 TRICYCLIC IMIDAZO-PYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY LP-PLA2 GLAXOSMITHKLINE IP DEV LTD (GB) 2019-07-03 EP disclosed